Received Sep 9, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
a reaction around the injection site; a sore arm for 1-2 days; This non-serious case was reported by a nurse via sales rep and described the occurrence of injection site reaction in a 50-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced injection site reaction (Verbatim: a reaction around the injection site) and pain in arm (Verbatim: a sore arm for 1-2 days). The outcome of the injection site reaction was resolved and the outcome of the pain in arm was resolved (duration 2 days). It was unknown if the reporter considered the injection site reaction and pain in arm to be related to Shingrix. It was unknown if the company considered the injection site reaction and pain in arm to be related to Shingrix. Linked case(s) involving the same patient: US2025AMR111180 Additional Information: GSK Receipt Date: 22-AUG-2025 The patient got a reaction around the injection site and had a sore arm for 1-2 days, since she got dose 2 of Shingrix. The patient recovered and was glad she got the Shingrix vaccine. For the tolerance of the first dose please refer to the case US2025AMR111180.; Sender's Comments: US-GSK-US2025AMR111180:Shingrix dose 1